The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomics In Cancer Care-Global Market Insights and Sales Trends 2024
Synopsis
The global Genomics In Cancer Care market size is expected to reach US$ 70990 million by 2029, growing at a CAGR of 14.2% from 2023 to 2029. The market is mainly driven by the significant applications of Genomics In Cancer Care in various end use industries. The expanding demands from the Diagnostics, Personalized Medicine, Drug Discovery and Development, are propelling Genomics In Cancer Care market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Consumables segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomics In Cancer Care market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomics In Cancer Care market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomics In Cancer Care, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomics In Cancer Care market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomics In Cancer Care market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomics In Cancer Care sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomics In Cancer Care covered in this report include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc.
The global Genomics In Cancer Care market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Pacific Biosciences
Quest Diagnostics
Luminex
Oxford Gene Technology
PerkinElmer
Qiagen
GE Healthcare
Global Genomics In Cancer Care market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomics In Cancer Care market, Segment by Type:
Instruments
Consumables
Services
Global Genomics In Cancer Care market, by Application
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomics In Cancer Care companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Genomics In Cancer Care market size is expected to reach US$ 70990 million by 2029, growing at a CAGR of 14.2% from 2023 to 2029. The market is mainly driven by the significant applications of Genomics In Cancer Care in various end use industries. The expanding demands from the Diagnostics, Personalized Medicine, Drug Discovery and Development, are propelling Genomics In Cancer Care market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Consumables segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomics In Cancer Care market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomics In Cancer Care market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomics In Cancer Care, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomics In Cancer Care market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomics In Cancer Care market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomics In Cancer Care sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomics In Cancer Care covered in this report include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc.
The global Genomics In Cancer Care market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Pacific Biosciences
Quest Diagnostics
Luminex
Oxford Gene Technology
PerkinElmer
Qiagen
GE Healthcare
Global Genomics In Cancer Care market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomics In Cancer Care market, Segment by Type:
Instruments
Consumables
Services
Global Genomics In Cancer Care market, by Application
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomics In Cancer Care companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomics In Cancer Care
1.1 Genomics In Cancer Care Market Overview
1.1.1 Genomics In Cancer Care Product Scope
1.1.2 Genomics In Cancer Care Market Status and Outlook
1.2 Global Genomics In Cancer Care Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomics In Cancer Care Market Size by Region (2018-2029)
1.4 Global Genomics In Cancer Care Historic Market Size by Region (2018-2023)
1.5 Global Genomics In Cancer Care Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomics In Cancer Care Market Size (2018-2029)
1.6.1 North America Genomics In Cancer Care Market Size (2018-2029)
1.6.2 Europe Genomics In Cancer Care Market Size (2018-2029)
1.6.3 Asia-Pacific Genomics In Cancer Care Market Size (2018-2029)
1.6.4 Latin America Genomics In Cancer Care Market Size (2018-2029)
1.6.5 Middle East & Africa Genomics In Cancer Care Market Size (2018-2029)
2 Genomics In Cancer Care Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Consumables
2.1.3 Services
2.2 Global Genomics In Cancer Care Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomics In Cancer Care Historic Market Size by Type (2018-2023)
2.2.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomics In Cancer Care Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomics In Cancer Care Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomics In Cancer Care Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomics In Cancer Care Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomics In Cancer Care Revenue Breakdown by Type (2018-2029)
3 Genomics In Cancer Care Market Overview by Application
3.1 Introduction
3.1.1 Diagnostics
3.1.2 Personalized Medicine
3.1.3 Drug Discovery
3.1.4 Development
3.1.5 Research
3.2 Global Genomics In Cancer Care Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomics In Cancer Care Historic Market Size by Application (2018-2023)
3.2.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomics In Cancer Care Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomics In Cancer Care Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomics In Cancer Care Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomics In Cancer Care Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomics In Cancer Care Revenue Breakdown by Application (2018-2029)
4 Genomics In Cancer Care Competition Analysis by Players
4.1 Global Genomics In Cancer Care Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
4.3 Date of Key Players Enter into Genomics In Cancer Care Market
4.4 Global Top Players Genomics In Cancer Care Headquarters and Area Served
4.5 Key Players Genomics In Cancer Care Product Solution and Service
4.6 Competitive Status
4.6.1 Genomics In Cancer Care Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina Genomics In Cancer Care Products, Services and Solutions
5.1.4 Illumina Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Thermo Fisher scientific
5.2.1 Thermo Fisher scientific Profile
5.2.2 Thermo Fisher scientific Main Business
5.2.3 Thermo Fisher scientific Genomics In Cancer Care Products, Services and Solutions
5.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher scientific Recent Developments
5.3 Agilent
5.3.1 Agilent Profile
5.3.2 Agilent Main Business
5.3.3 Agilent Genomics In Cancer Care Products, Services and Solutions
5.3.4 Agilent Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Genomics In Cancer Care Products, Services and Solutions
5.4.4 Roche Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Cancer Genetics
5.5.1 Cancer Genetics Profile
5.5.2 Cancer Genetics Main Business
5.5.3 Cancer Genetics Genomics In Cancer Care Products, Services and Solutions
5.5.4 Cancer Genetics Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.5.5 Cancer Genetics Recent Developments
5.6 Beckman Coulter
5.6.1 Beckman Coulter Profile
5.6.2 Beckman Coulter Main Business
5.6.3 Beckman Coulter Genomics In Cancer Care Products, Services and Solutions
5.6.4 Beckman Coulter Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.6.5 Beckman Coulter Recent Developments
5.7 Bio-Rad
5.7.1 Bio-Rad Profile
5.7.2 Bio-Rad Main Business
5.7.3 Bio-Rad Genomics In Cancer Care Products, Services and Solutions
5.7.4 Bio-Rad Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Recent Developments
5.8 Danaher
5.8.1 Danaher Profile
5.8.2 Danaher Main Business
5.8.3 Danaher Genomics In Cancer Care Products, Services and Solutions
5.8.4 Danaher Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.8.5 Danaher Recent Developments
5.9 Sigma Aldrich
5.9.1 Sigma Aldrich Profile
5.9.2 Sigma Aldrich Main Business
5.9.3 Sigma Aldrich Genomics In Cancer Care Products, Services and Solutions
5.9.4 Sigma Aldrich Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.9.5 Sigma Aldrich Recent Developments
5.10 Pacific Biosciences
5.10.1 Pacific Biosciences Profile
5.10.2 Pacific Biosciences Main Business
5.10.3 Pacific Biosciences Genomics In Cancer Care Products, Services and Solutions
5.10.4 Pacific Biosciences Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.10.5 Pacific Biosciences Recent Developments
5.11 Quest Diagnostics
5.11.1 Quest Diagnostics Profile
5.11.2 Quest Diagnostics Main Business
5.11.3 Quest Diagnostics Genomics In Cancer Care Products, Services and Solutions
5.11.4 Quest Diagnostics Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.11.5 Quest Diagnostics Recent Developments
5.12 Luminex
5.12.1 Luminex Profile
5.12.2 Luminex Main Business
5.12.3 Luminex Genomics In Cancer Care Products, Services and Solutions
5.12.4 Luminex Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.12.5 Luminex Recent Developments
5.13 Oxford Gene Technology
5.13.1 Oxford Gene Technology Profile
5.13.2 Oxford Gene Technology Main Business
5.13.3 Oxford Gene Technology Genomics In Cancer Care Products, Services and Solutions
5.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.13.5 Oxford Gene Technology Recent Developments
5.14 PerkinElmer
5.14.1 PerkinElmer Profile
5.14.2 PerkinElmer Main Business
5.14.3 PerkinElmer Genomics In Cancer Care Products, Services and Solutions
5.14.4 PerkinElmer Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.14.5 PerkinElmer Recent Developments
5.15 Qiagen
5.15.1 Qiagen Profile
5.15.2 Qiagen Main Business
5.15.3 Qiagen Genomics In Cancer Care Products, Services and Solutions
5.15.4 Qiagen Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.15.5 Qiagen Recent Developments
5.16 GE Healthcare
5.16.1 GE Healthcare Profile
5.16.2 GE Healthcare Main Business
5.16.3 GE Healthcare Genomics In Cancer Care Products, Services and Solutions
5.16.4 GE Healthcare Genomics In Cancer Care Revenue (US$ Million) & (2018-2023)
5.16.5 GE Healthcare Recent Developments
6 North America
6.1 North America Genomics In Cancer Care Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomics In Cancer Care Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomics In Cancer Care Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomics In Cancer Care Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomics In Cancer Care Market Dynamics
11.1 Genomics In Cancer Care Industry Trends
11.2 Genomics In Cancer Care Market Drivers
11.3 Genomics In Cancer Care Market Challenges
11.4 Genomics In Cancer Care Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
